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ABSTRACT
Galectin-1 (Gal1) is a known immune/inflammatory regulator which acts 
both extracellularly and intracellularly, modulating innate and adaptive immune 
responses. Here, we explored the role of Gal1 in liver regeneration using 70% partial 
hepatectomy (PHx) of C57BL/6 wild type and Gal1-knockout (Gal1-KO, Lgals1-/-) 
mice. Gene or protein expression, in liver samples collected at time intervals from 
2 to 168 hours post-operation, was tested by either RT-PCR or by immunoblotting 
and immunohistochemistry, respectively. We demonstrated that Gal1 transcript and 
protein expression was induced in the liver tissue of wild type mice upon PHx. Liver 
regeneration following PHx was significantly delayed in the Gal1-KO compared to the 
control liver. This delay was accompanied by a decreased Akt phosphorylation, and 
accumulation of the hepatocyte nuclear p21 protein in the Gal1-KO versus control 
livers at 24 and 48 hours following PHx. Transcripts of several known regulators of 
inflammation, cell cycle and cell signaling, including some known PHx-induced genes, 
were aberrantly expressed (mainly down-regulated) in Gal1-KO compared to control 
livers at 2, 6 and 24 hours post-PHx. Transient steatosis, which is imperative for liver 
regeneration following PHx, was significantly delayed and decreased in the Gal1-
KO compared to the control liver and was accompanied by a significantly decreased 
expression in the mutant liver of several genes encoding lipid metabolism regulators. 
Our results demonstrate that Gal1 protein is essential for efficient liver regeneration 
following PHx through the regulation of liver inflammation, hepatic cell proliferation, 
and the control of lipid storage in the regenerating liver.
INTRODUCTION
Galectin-1 (Gal1) is a  β-galactoside-binding lectin, 
encoded by the Lgals1 gene, which is widely expressed 
in multiple cell types including immune cells and acts 
both extracellularly and intracellularly, modulating 
innate and adaptive immune responses. This lectin 
blunts inflammatory responses by promoting apoptosis 
of activated, but not resting T cells, suppressing the 
secretion of pro-inflammatory cytokines and favoring 
secretion of anti-inflammatory IL-10 [1, 2]. Gal1 is also a 
key effector of regulatory T cells and suppresses chronic 
inflammation in different experimental models [1, 3]. 
Over-expression of Gal1 in different tumor types and/
or their associated stroma promotes tumor progression 
through multiple mechanisms including inhibition of 
efficient anti-tumor immune response [1, 4], augmentation 
of Ras activation [5], stimulation of tumor angiogenesis 
[6, 7], and activation of p38 MAPK, ERK1/2 and COX-
2 signaling pathways [8]. Interestingly, nuclear factor 
(NF)-κB controls expression of Gal1, which may in turn 
attenuate activation of this transcription factor through a 
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self-regulatory mechanism [9]. Moreover, recent studies 
identified a role for Gal1 as a compensatory mechanism 
that preserves angiogenesis in anti-VEGF refractory 
tumors by co-opting the VEGFR2 signaling pathway [10], 
suggesting that it may mimic canonical ligands to sustain 
signaling pathways in different biological processes. 
Expression of Gal1 is associated with the 
aggressiveness of hepatocellular carcinoma (HCC) in 
mice [11], low survival of HCC patients [12], and poor 
prognosis in HCC following resection [13]. Interestingly, 
Gal1 acts by promoting HCC cell adhesion through 
PI3K and/or ERK1/2 signaling pathways [14]. In murine 
HCC models, we have demonstrated that an inefficient 
anti-inflammatory activity of the endogenous Gal1 is 
associated with increased inflammation at an early age and 
with enhanced tumor development at an older age [15]. On 
the other hand, the tumor-promoting effect of the hepatitis 
C virus (HCV) transgene in the chronic inflammation-
mediated HCC mouse model, was associated with 
increased Gal1 expression in the liver [16]. Notably, this 
lectin can also either activate or inhibit cell proliferation 
depending on cell type and cell activation status [1]. 
Based on the multiple activities of Gal1, we investigated 
whether Gal1 controls hepatocarcinogenesis, at least in 
part, through direct effects on hepatocyte proliferation in 
the injured liver.
Here we have identified a role for Gal1 in liver 
regeneration (LR) following partial hepatectomy (PHx). 
LR following 70% PHx is a highly ordered and well 
studied process of compensatory hyperplasia which 
restores the liver mass by a combination of hepatocyte 
proliferation and hypetrophy [17]. This process is 
controlled by three main partially overlapping and 
redundant networks: cytokines, growth factors, and 
metabolic regulators [18, 19]. There is a constantly 
growing list of so called auxiliary mitogens which 
typically are not mitogenic for hepatocytes in vivo or in 
vitro when supplemented directly, although their absence 
causes a significant delay in LR [20]. We found that 
Gal1 deficiency results in a significant retardation of LR 
following PHx, through mechanisms involving selective 
regulation of PHx-induced genes including inflammatory 
mediators as well as regulators of cell cycle and lipid 
metabolism.
RESULTS
Delayed recovery of liver mass in Gal1-KO mice 
following partial hepatectomy
To explore the potential role of Gal1 in the 
regulation of hepatocyte proliferation, we used PHx as a 
well-established method for studying LR. Isogenic wild 
type (WT) and Gal1-KO mice underwent either 70% PHx 
or sham surgery and were sacrificed at 2, 6, 24, 48, 72, 96 
and 168 hours after operation. Liver and serum samples 
were collected for subsequent analysis. Restoration of the 
liver mass following PHx was significantly attenuated 
in Gal1-KO mice as compared to WT mice at 48 to 96 
hours post-operation (Figure 1A). Nevertheless, at 168 
hours (7 days) following PHx, the liver mass in the Gal1-
KO mutants was completely restored, as in the WT mice 
(Figure 1A). Notably, body weights of both groups of mice 
recovering from PHx were comparable (data not shown). 
Monitoring markers of the proliferative machinery 
demonstrated a reduced level of BrdU incorporation into 
hepatocyte nuclei of Gal1-KO compared to WT mice at 
48 hours following PHx, while the situation reversed at 96 
hours following PHx (Figure 1B, Supplementary Figure 
1A). In parallel, phosphorylation of histone H3, which 
is a highly specific marker of mitosis, was significantly 
reduced in the hepatocyte nuclei of Gal1-KO compared to 
WT mice at 48 and 72 hours following PHx, while it was 
significantly increased in mutants at 96 hours following 
PHx (Figure 1C, Supplementary Figure 1B). Thus, loss 
of Gal1 resulted in a significant retardation of hepatocyte 
DNA synthesis, of hepatocyte proliferation, and of 
restoration of liver mass following PHx. 
Absence of Gal1 results in aberrant expression of 
cell cycle regulatory proteins in the regenerating 
mutant liver
 To explore the possible molecular mechanisms 
underlying the delayed DNA replication and hepatocyte 
proliferation in the regenerating livers of Gal1-KO 
mice, we compared the expression of the cyclin D1, p21 
and phosphorylated Akt proteins in WT and Gal1-KO 
regenerating livers (Figure 2 & Supplementary Figure 
2). Concomitantly with the reduction of hepatocyte 
proliferation in Gal1-KO mice versus WT mice, a 
significant decrease in the levels of cyclin D1 was 
observed in both hepatocytes and non-parenchymal cells 
of the mutant liver at 24 and 48 hours post-PHx. However, 
at 72 and 96 hours post-PHx, cyclin D1 expression was 
significantly higher in all cell types of Gal1-KO compared 
to WT mice (Figure 2A, 2B; Supplementary Figure 2A). 
Level of the p21 protein, which is believed to inhibit 
cell cycle progression, was significantly increased in 
hepatocyte nuclei of Gal1-KO versus WT mice at 24 and 
48 hours post-PHx (Figure 2C; Supplementary Figure 2B). 
As expected, p21 expression was not detected in the naïve 
and sham-operated livers of both congenic strains (data 
not shown).
We also tested the phosphorylation status of 
several important mitogenic signaling proteins, essential 
for cell proliferation. We found no difference in the 
phosphorylation of STAT3, mitogen activated protein 
kinases (MAPKs) and p38 between Gal1-KO and 
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Figure 1: Delayed liver regeneration following PHx in Gal1-KO (Lgals1-/-) mice. A. Liver-to-body weight ratios (%) in WT 
versus Gal1-KO mice at different time points following PHx . B. Quantification of the BrdU-positive hepatocyte nuclei at 24 to 96 hours 
following PHx. C. Quantification of hepatocyte nuclei positive for phosphorylated histone 3 (pH3) in regenerating livers post-PHx. B. and 
C. on “y” axis - average numbers of positive nuclei per one HPF; at least 10 HPFs were counted per each liver sample. Standard deviation 
and statistical significance (t-test) are shown: *, P < 0.05 and **, P < 0.005; 5 - 6 males per each experimental group.
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Figure 2: Aberrant expression of several cell cycle related proteins in the liver of WT and Gal1-KO mice following 
PHx. A., B. Quantification of cyclin D1-positive nuclei in hepatocytes A. and non-parenchymal cells B. of the Gal1-KO versus WT 
post-pHx livers, assessed by IHC. C. Quantification of the p21-positive hepatocyte nuclei at 24, 48 and 72 hours following PHx. A., B., 
C. on “y” axis - average numbers of positive nuclei per one HPF; at least 10 HPFs were counted per each liver sample; 6 males per each 
experimental group. D. Phosphorylation of the Akt protein was evaluated by immunoblotting of the whole liver homogenates obtained 
from WT and Gal1-KO mice at 2, 6, 24 and 48 hours post-PHx (upper panel for each time point);  β-actin ( βAct) was used as a loading 
control (bottom panel for each time point). E. Densitometric analysis of the pAkt protein expression presented at D. each pAkt band was 
normalized to the matched  β-actin band followed by normalization of each Gal1-KO value to the matched WT value. Three to four males 
per each experimental group; standard deviation and statistical significance (t-test) are shown: *, P < 0.05; **, P < 0.005.
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WT livers at the time points studied following PHx 
(data not shown). Meanwhile, there was a noticeable 
variation in the phosphorylation (and activation) of the 
Akt protein in Gal1-KO relative to the WT liver within 
2 and 48 hours post-operation: Akt phosphorylation 
was significantly reduced at 2 and 6 hours, while it 
was significantly increased at 48 hours post-PHx in the 
mutant liver (Figure 2D, 2E). The aberrant expression 
patterns of cyclin D1, p21 and phosphorylated Akt in 
the Gal1-KO livers following PHx are in accordance 
with the observed retardation of liver mass recovery and 
hepatocyte proliferation in mutant mice, thus underscoring 
the essential role of Gal1 in the regulation of critical 
intracellular signals and molecular markers associated 
with hepatocyte proliferation during LR.
Gal1 induction following PHx
We examined whether Gal1 is induced in WT 
mice during the first 24 hours of LR following 70% 
PHx, and found a significant induction of the Gal1 
transcript in the regenerating post-PHx compared to the 
sham-operated liver at 6, but not at 2 hours following 
operation (Figure 3A).The level of Gal1 protein in the 
liver of hepatectomized mice was not increased at 6 
hours following PHx (not shown), but it was significantly 
increased at 24 hours compared to both hepatectomized 
mice at 6 hours post-PHx (Figure 3B) and to sham-
operated controls at 24 hours post-PHx (Figure 3C, 
3D, Supplementary Figure 3A). Increased Gal1 protein 
expression was detected also by IHC in the post-PHx 
compared to the sham-operated liver of WT mice at all 
tested time points following operation (Supplementary 
Figure 3B). In both sham-operated and post-PHx WT 
livers, Gal1 was expressed mainly by endothelial 
cells, by lymphocytes, and by pericentral hepatocytes. 
Given the established role of galectin-3 in regulating 
cell proliferation [21], we examined whether altered 
galectin-3 expression could compensate for the loss of 
the Gal1 protein in LR. Hepatic expression of galectin-3 
was similarly increased in Gal1-KO and WT livers both 
at 6 and at 24 hours post-PHx (Figure 3E). These findings 
demonstrate that Gal1 is induced during the first day of 
LR following PHx in WT mice, and that its loss is not 
compensated by altered galectin-3 expression.
Decreased inflammation in the livers of Gal1-KO 
mice one day following PHx
Examination of the liver enzyme activity in the 
serum of WT and Gal1-KO mice during LR revealed no 
significant differences between the genotypes except at 72 
hours following PHx, when the levels of ALP decreased in 
Gal1-KO versus WT mice, possibly indicating a reduced 
biliary damage in the mutant mouse liver (Supplementary 
Figure 4A, 4B). Sham-operated mice did not exhibit any 
signs of hepatocyte or biliary damage (shown only at 2 and 
6 hours post-PHx). The frequency of apoptotic cells during 
LR (measured by TUNEL assay) was also similar between 
the WT and Gal1-KO livers, with very few apoptotic 
hepatocytes detected in both groups (data not shown). 
Thus, the overall level of liver tissue injury following PHx 
was not affected by Gal1 loss. Based on the established 
anti-inflammatory activity of Gal1, we evaluated the 
expression of several inflammation-related genes in the 
regenerating WT and Gal1-KO livers at 24 hours post-PHx 
using both semi-qRT-PCR (Figure 4A, Supplementary 
Figure 5A) and qRT-PCR (Figure 4B, Supplementary 
Figure 5B). Unexpectedly, the genes Tnfa, Cd36, Ccr1, 
Tnfaip3, and Tgfb were found to be down-regulated, 
while Zfp36 was up-regulated in Gal1-KO compared to 
WT livers (Figure 4A, 4B; genes that were not affected 
by Gal1 loss are shown in Supplementary Figure 5B). 
Interestingly, Flt1 (Vegfr1, encoding receptor for vascular 
endothelial growth factor 1) was also significantly down-
regulated in the Gal1-KO liver. As a control, we also tested 
Gal1 expression in these experimental groups, at 24 hours 
post-PHx: both semi-qRT-PCR and qRT-PCR detected the 
Gal1 transcript only in the WT, but not in the Gal1-KO 
liver (not shown).
Given the importance of monocytes and 
macrophages in LR, we then assessed their infiltration 
into the liver parenchyma by immunostaining for F4/80, 
a marker of mature mouse macrophages and blood 
monocytes. The number of macrophages and monocytes 
was decreased in the Gal1-KO versus WT livers at 24 
hours, while it was substantially increased at 72 hours 
following PHx (Figure 4C and Supplementary Figure 
6). Monocytes and macrophages accumulated mainly in 
the portal tracts of both congenic livers following PHx. 
Remarkably, the expression of the Cd14 gene, which 
is expressed mainly by macrophages and, to a lesser 
extent, by neutrophils, was significantly reduced in Gal1-
KO compared to WT livers at 2, 6 and 24 hours post-
PHx (Figure 5A, 5B and Figure 4D). The expression 
of the Ccl3 (Mip1α) gene, which encodes a chemokine 
promoting macrophage chemoattraction and influencing 
wound healing and inflammation, was significantly down-
regulated in the Gal1-KO compared to the WT liver at 
24 hours post-PHx (Figure 4B). Thus, Gal-1 may control 
LR, at least in part, through regulation of inflammatory 
responses.
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Figure 3: Induction of the Gal1 gene (Lgals1) in regenerating WT livers early following PHx. A. Quantification of the 
Gal1 transcript level in WT livers at 6 hours post-PHx and in to sham-operated livers by qRT-PCR. B. and C. Testing the Gal1 protein 
level (~14.5 kDa) in WT livers at 24 hours following PHx compared to either 6 hours following PHx B. or sham-operated controls at 24 
hours following PHx C. by immunoblotting. D. Quantification of data shown in C.. E. Lack of Gal1 does not affect the expression of the 
galectin-3 (Gal3, Lgals3) gene at either 6 or 24 hours following PHx (qRT-PCR). In all experiments: 3 - 4 male mice per experimental 
group; statistical significance (t-test): *, P < 0.05, **, P < 0.005. 
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Table 1: RT-PCR analysis of liver gene expression following PHx in the Gal1-KO compared to WT mice.
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Gal1 deficiency influences the expression of 
multiple genes in the early stages of LR following 
PHx
 We then studied whether Gal1 deficiency alters 
the expression of genes known to be induced at the very 
early stages of LR following PHx using qRT-PCR. For 
this purpose, we selected 32 genes that are involved in 
the control of inflammation and cell proliferation (many 
of them are known as PHx-induced genes; Table 1). Lack 
of Gal1 affected the expression of eight genes at 2 hours 
post-PHx (Figure 5A) and of six genes at 6 hours post-
PHx (Figure 5B); only Cd14, Ltbr and Myc were affected 
at both time points. Two hours post-PHx, six genes were 
found to be down-regulated and two were found to be 
up-regulated in Gal1-KO compared to WT liver (Figure 
5A), whereas at 6 hours post-PHx, only two genes were 
down-regulated while four were up-regulated in the Gal1-
KO compared to the WT liver (Figure 5B). However, 
only in six tested cases, the difference in gene expression 
between mutants and controls reached or exceeded the 
two-fold threshold: Gal1 absence caused a three-fold 
down-regulation of the genes Atf3, Cd14 and Il6 at 2 hours 
post-PHx, and a 2.5-fold down-regulation of the gene 
Ltbr with a two-fold up-regulation of the genes Zfp36 and 
Figure 4: Decreased hepatic inflammation in Gal1-KO mice at the early stages of LR following PHx. A., B. Graphical 
representations of differential expression of the tested inflammation- and angiogenesis-related genes in the regenerating WT and Gal1-KO 
livers at 24 hours post-PHx. A. Semi-qRT-PCR, in triplicates. B. qRT-PCR analysis of liver gene expression, in triplicates (RQ - relative 
quantification). C. Histomorphometric quantification of monocytes/macrophages in the liver is represented as an average number of F4/80-
positive non-parenchymal cells per one HPF. D. Expression of the Cd14 transcript in Gal1-KO and WT livers at 24 hours following either 
PHx or sham surgery (qRT-PCR). In all experiments: 3 - 4 male mice per experimental group; reference genes: Mrps21 - in A., Hprt - in B. 
and in D.; statistical significance (t-test): *, P < 0.05; **, P < 0.005. 
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Figure 5: Aberrant expression of genes, known to be induced in LR, in the liver of Gal1-KO compared to WT mice. 
Gene expression in the liver at 2 hours A. and 6 hours B. following either PHx (grey color) or sham (white color) surgeries. Real-Time RT-
PCR using Hprt gene expression as an internal control; 4 - 5 male mice per experimental group. In all experiments, data represent mean ± 
SD; statistical significance (t-test): *, P < 0.05, **, P < 0.02, ***, P < 0.005. 
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Tnfaip3 at 6 hours post-PHx. Four among these six genes 
have well established roles in the regulation of LR. IL-6 
is one of the main pro-inflammatory and regeneration-
promoting cytokines in the priming phase of LR, which 
induces the expression of about 40% of the immediate 
early genes in the regenerating liver [18]. Atf3 (Lrf-1, 
liver regenerating factor 1) induces DNA synthesis and 
cyclin D1 expression [22]. Both Il6 and Atf3 genes were 
induced already at 2 hours post-PHx in the WT, but not 
in the Gal1-KO liver (Figure 5A). Signaling through Ltbr 
(receptor for lymphotoxin- β) is essential for efficient LR, 
specifically - for initiation of DNA synthesis [23]. Tnfaip3 
(A20) is a potent inhibitor of inflammation and of NF-κB 
activation [24]. 
Loss of Gal1 results in aberrant lipid metabolism 
in the regenerating mutant liver
Comparative histological analysis of regenerating 
livers revealed a significantly reduced temporal steatosis 
in the Gal1-KO compared to control WT mice at 24, 
48, and 72 hours following PHx (Supplementary Figure 
7A). Immunohistochemical staining of liver sections for 
adipophilin (perilipin 2, a specific marker of lipidogenesis 
encoded by the gene Plin2) revealed a reduced expression 
of this protein showing a one-day delay in its appearance 
in the Gal1-KO compared to WT post-PHx livers (Figure 
6A). There was a negligible staining for adipophilin in the 
naïve livers of both congenic strains (data not shown) as 
well as in the sham operated livers of both congenic strains 
(Supplementary Figure 7B). Direct quantification of the 
triglycerides level in liver tissue samples demonstrated 
a significantly reduced level of triglycerides in Gal1-KO 
compared to WT liver at 48 hours post-PHx (Figure 6B).
To explore the underlying molecular mechanisms of 
aberrant lipidogenesis in Gal1-KO livers, we examined the 
expression of Cidec, Fabp4, Plin4, and Acly genes which 
are responsible of regulating this process, in the liver of 
both strains (Figure 6C). While the Cidec (Fsp27) protein 
promotes the formation and enlargement of lipid droplets 
[25], Fabp4, the fatty acid binding protein, functions in 
the fatty acid uptake, transport, and metabolism, and the 
Plin4 protein, similar to Plin2, coats intracellular lipid 
storage droplets. On the other hand, Acly (ATP citrate-
lyase) is a cytosolic enzyme responsible for the synthesis 
of acetyl-CoA in many tissues and connects glucose/
glutamine metabolism to the de novo lipid synthesis [26]. 
The expression of all four tested genes was significantly 
reduced in the Gal1-KO compared to the control WT 
liver: Acly - at 6 hours, Cidec - at 24 hours, while Fabp4 
and Plin4 - both at 6 and 24 hours post-PHx (Figure 6C). 
The most significant alteration (at least, two-fold) was a 
decrease of Cidec and Fabp4 expression at 24 hours post-
PHx. These two genes were induced in both genotypes at 6 
and 24 hours post-PHx, compared to sham-operated mice. 
Interestingly, aberrant lipidogenesis in the Gal1-KO post-
PHx liver correlated with the reduced size of hepatocytes 
in mutants compared to controls at 48 and 72 hours 
following operation, as revealed by immunohistochemical 
staining of liver sections for  β-catenin (Supplementary 
Figure 8). 
DISCUSSION
The endogenous lectin Gal1 is mainly known for its 
regulatory role in the regulation of immune cell programs, 
inflammatory responses and angiogenesis; however it 
has also been implicated in the control of cell survival, 
signaling and proliferation, acting in different model 
systems either as a mitogen or as an inhibitor of cell 
proliferation [1, 11]. Here we identified a novel role for 
Gal1 in LR following PHx. Our findings reveal that Gal1 
is induced already at 6 hours post-PHx, and is essential 
for an efficient LR by stimulating different processes 
in the liver, including early inflammation, hepatocyte 
proliferation, liver adipogenesis and angiogenesis 
(Supplementary Figure 9). Interestingly, previous studies 
showed that Gal1 promotes peripheral nerve regeneration 
by different molecular mechanisms, including macrophage 
stimulation [27, 28]. In line with these findings, we 
demonstrate here that Gal1 deficiency significantly 
reduced the recruitment of monocytes/macrophages during 
the first 24 hours post-PHx (Figure 4C, 4D) and resulted in 
a decreased expression of the genes Tnfa, encoding TNFα, 
one of the main regulators of LR, and Ccl3, encoding a 
chemokine Mip1α that promotes monocyte/macrophage 
chemoattraction (Figure 4A, 4B). The earliest effects 
of Gal1 loss in the regenerating liver were the absence 
of induction of the Atf3, Il6 and Cd14 genes at 2 hours 
post-PHx (Figure 5A). Moreover, at 6 hours post-PHx, 
loss of Gal1 caused a decreased expression of Ltbr and 
an increased induction of the genes Tnfaip3 and Zfp36 
both of which encode potent inhibitors of inflammation 
(Figure 5B). Remarkably, during the first 24 hours post-
PHx, loss of Gal1 resulted mainly in a reduced induction 
or expression of multiple genes; only two genes, Tnfaip3 
and Zfp36, both negative regulators of inflammation, were 
up-regulated in the Gal1-KO hepatectomized liver (Table 
1).
Interestingly, Tnfaip3 encodes the ubiquitin-
modifying enzyme A20 which restricts the duration and 
intensity of NF-κB signaling and, in turn, is induced by 
NF-κB [24]. This negative feedback of NF-κB signaling 
is common for both A20 and Gal1 [9]. Recently, it was 
demonstrated that A20 promotes LR by decreasing SOCS3 
expression and enhancing the IL-6/STAT3 proliferation 
signaling pathway [29]. Thus, down-regulation of the 
Tnfaip3 expression at 24 hours post-PHx (Figure 4B) 
could be one of the reasons for a retarded LR in the Gal1-
KO liver. We detected no changes in the expression of the 
Socs3 and Saa1 genes in the Gal1-KO liver at 24 hours 
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Figure 6: Significantly delayed and decreased transient steatosis in the Gal1-KO compared to WT liver following PHx. 
A. Immunohistochemical staining of liver sections for adipophilin (arrow) in the Gal1-KO compared to WT liver at 24, 48 and 72 hours 
following PHx. Magnification x100; insert x400. B. Levels of triglycerides in the Gal1-KO compared to WT liver samples at 48 hours 
following PHx (Triglyceride Quantification Colorimetric/Fluorometric Kit #K622, Biovision Inc., Milpitas, CA; three males per each 
experimental group); C. Expression of adipogenic genes in the Gal1-KO compared to WT liver at 6 and/or 24 hours post-PHx. Real time 
RT-PCR using Hprt gene expression as the internal control; 4 - 5 male mice per group. Data represent mean ±SD; statistical significance 
(t-test): *, P < 0.05, **, P < 0.02. 
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post-PHx (Table 1 and Supplementary Figure 5B; Saa1 
has been tested as an established target of the IL-6/STAT3 
signaling). Nevertheless, p21 protein, whose expression is 
known to be down-regulated in response to an excess of 
A20 [30], was found to be up-regulated in the post-PHx 
Gal1-KO liver (Figure 2C), in agreement with the reduced 
Tnfaip3 expression at 24 hours post-PHx. Thus, our data 
demonstrate that absence of Gal1 causes an aberrant 
response of the Tnfaip3 gene encoding A20 protein on 
PHx: up-regulation at 6 and down-regulation at 24 hours 
post-operation, suggesting a decreased NF-κB signaling 
which promotes LR at this stage. 
Zfp36 encodes tristetraprolin, which negatively 
regulates the expression of multiple genes, including many 
cytokines, mainly by promoting a rapid decay of their 
transcripts [31]. Among its known targets are Tnfa, Ccl3 
and Csf2, encoding the granulocyte-macrophage colony-
stimulating factor GM-CSF [31]. Thus, a pronounced 
up-regulation of Zfp36 in Gal1-KO compared to the WT 
liver both at 6 and 24 hours post-PHx (Figure 5B, Figure 
4B), could be one of the factors responsible for the down-
regulation of Tnfa and Ccl3 and for the delayed monocyte/
macrophage recruitment in mutants at 24 hours post-PHx 
(Figure 4). Despite the well-known up-regulation of Zfp36 
expression early following PHx [32], its function in LR 
has not been explored. We suggest that tristetraprolin, A20 
and Gal1, represent a group of stress-induced regulators 
of inflammation and cell proliferation with partially 
overlapping functions. The well-known redundancy of LR 
mechanisms may explain the early induction of Zfp36 and 
Tnfaip3 in the absence of Gal1.
IL-6, a well-established pro-inflammatory and pro-
angiogenic cytokine, has been identified as a key feature 
of LR [18]. Notably, the induction of Il6 expression was 
abolished in the Gal1-KO liver at 2 hours post-PHx, 
but was comparable to that in the WT liver at 6 and 24 
hours post-PHx (Figure 5A, Table 1). Because some 
studies confirm the importance of IL-6 for LR following 
PHx, while others do not - the precise roles of IL-6 in 
LR still remain uncertain [18]. Here we have examined, 
among others, the expression of 11 genes that were 
previously shown to be induced at 2 hours post-PHx in 
an IL-6-dependent fashion [32]. Despite the lack of Il6 
induction in the Gal1-KO liver at 2 hours post-PHx, the 
IL-6-dependent genes did not show a defined pattern of 
expression at either 2 or 6 hours post-PHx: some of them 
were up-regulated, some - down-regulated, and some had 
similar expression levels in mutants and controls (Table 1). 
Thus, it is difficult to delineate the precise consequences 
of the absence of early Il6 induction in the Gal1-KO post-
PHx liver. If IL-6 regulates some genes in concert with 
Gal1 (or a Gal1-dependent regulator), then, in the absence 
of Gal1, such genes may turn to be IL-6-independent. 
In this regard, recent studies revealed that the microbe-
driven IL-6 inflammation contributes to tumor progression 
through Gal1-dependent mechanisms [33].
The most significant effects of Gal1 loss on the cell 
cycle machinery were the reduced Akt phosphorylation at 
2 and 6 hours post-PHx (Figure 2D, 2E), the absence of 
Atf3 induction at 2 hours post-PHx (Figure 5A), and the 
decreased cyclin D1 and increased p21 levels at 24 and 
48 hours post-PHx (Figure 2A-2C). Akt is phosphorylated 
(and activated) early in LR following PHx by TNFα and 
by growth factor signaling [18]. Whereas Akt is activated 
by IL-6 [34] the lack of IL-6 induction at 2 hours post-PHx 
could be one of the factors contributing to the diminished 
Akt activation in the Gal1-KO liver. Although in non-
hepatocyte cells, p21 phosphorylation by Akt prevents its 
association with PCNA, which inhibits DNA replication 
[35], in LR, activated Akt stimulates the restoration of 
hepatocyte size and may promote hepatocyte proliferation 
only in the absence of p21 [36]. The Atf3 gene encodes the 
activating transcription factor 3 which is also called LR 
factor 1 (LRF-1). The absence of its induction in the Gal1-
KO liver early post-PHx might contribute to a retarded 
DNA synthesis and to decreased levels of the cyclin D1 
protein, since Atf3 directly activates its transcription in 
hepatocytes [22]. The significantly increased expression 
of nuclear p21 in the hepatocytes of Gal1-KO mice at 24 
and 48 hours post-PHx might be one of the main factors 
responsible for the retardation of LR in mutants. 
Our findings showing a decreased accumulation 
of lipids in the Gal1-KO liver post-PHx demonstrate for 
the first time the influence of an endogenous lectin on 
lipid metabolism in the liver. Transient hepatic steatosis 
in the regenerating liver is a well-known phenomenon; 
despite highly controversial studies on the significance 
of specific lipid metabolism genes for an efficient LR, 
most published data show that altered lipid metabolism, 
including accumulation of lipid droplets, in the post-
PHx liver is functionally important for the initiation of 
LR [37]. At the molecular level, we demonstrated that 
Gal1 loss resulted in a decreased transcript expression 
for several genes encoding proteins that are associated 
with the formation of lipid droplets. Interestingly, we 
found a reduced expression of adipophilin (perilipin-2), 
in the liver of Gal1-KO mice during first three days 
following PHx (Figure 6A). The functional relevance 
of this protein in LR following PHx has been confirmed 
recently by the demonstration of delayed LR in Plin2-KO 
mice [38]. Hence, the insufficient lipid accumulation in 
the post-PHx mutant liver could be an additional factor 
responsible for the retardation of LR in Gal1-KO mice. 
Remarkably, we found a significantly reduced expression 
of the Ltbr gene (but not of its ligands’ genes) in the 
early post-PHx stage (Figure 5, Table 1). The Ltbr gene 
encodes the lymphotoxin- β receptor which controls both 
LR (specifically - initiation of DNA synthesis) and lipid 
metabolism in the liver [23, 39].
It is well known that the functional activity of 
galectins significantly depends on their carbohydrate 
ligands [40]. Although the impact of Gal1 carbohydrate 
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ligands has been explored in several cells and tissues, 
their relevance in liver physiology is less understood. 
In this regard, recent studies have shown that complex 
branched N-glycans, structures that are generated by the 
Mgat5 glycosyltransferase and serve as Gal1 ligands, play 
key roles in glycemic responses to exogenous glucagon 
in hepatocytes. In fact, glucagon receptor signaling and 
gluconeogenesis were impaired in Mgat5-/- cultured 
hepatocytes [41]. Moreover, analysis of hepatocarcinoma 
cells revealed substantial glycan changes during epithelial 
mesenchymal transition, including increased β1-6 
N-glycan branching and decreased α2,6 sialylation, 
suggesting higher exposure of Gal1-specific glycoepitopes 
during this protumorigenic process [42]. Finally, Mgat5-
mediated β-1-6-GlcNAc branched N-glycosylation 
conferred hepatic cells with resistance to anoikis through 
EGFR/PAK1 activation [43]. 
Finally, we found that Gal1 loss resulted in the 
reduced expression of the Flt1 (Vegfr1) transcript 
encoding VEGFR1 (Figure 4A, Supplementary Figure 
5A). In this regard, the pro-angiogenic activity of Gal1 
has been identified mainly in the context of tumor neo-
vascularization under hypoxic conditions [6, 7], and 
contributed to VEGFR2, but not to VEGFR1 signaling 
due to the differential sialylation of these glycosylated 
receptors [10]. In conclusion, our results demonstrate 
that Gal1 expression is induced early following 70% 
PHx, and that Gal1 is essential for an efficient LR 
through the activation of multiple molecular pathways. 
Gal1 loss resulted in a significantly delayed hepatocyte 
proliferation and liver mass restoration, which were 
accompanied by a delay in monocyte/macrophage 
recruitment, and a decrease in transient liver post-PHx 
steatosis (Supplementary Figure 9). Based on the well 
known redundancy of signaling networks directing LR, we 
propose that Gal1 could act hierarchically in this process 
in concert with other regulators of inflammation, cell 
cycle, lipid metabolism and angiogenesis. Further analysis 
is required to elucidate the complex interactions of these 
signaling networks in LR, and the functional relevance of 
the Gal1-glycan axis in physiologic and pathologic liver 
conditions.
MATERIALS AND METHODS
Full details are available in the Supplementary 
Methods.
Mice
Mice were maintained at the Specific Pathogen-
Free unit of the Animal Facility, The Hebrew University 
Medical School, under a 12 h light/dark cycle, and 
provided with food and water ad libitum. All animals 
received human care, and all animal study protocols were 
approved by the Hebrew University-Hadassah Medical 
School Ethics Review Board (the Animal Care Unit holds 
National Institutes of Health (NIH) approval number 
OPRR-A01-5011 and the American Association for the 
Accreditation of Laboratory Animal Care International 
accreditation number 1285). Wild type C57Bl/6 (B6) 
mice were obtained from Harlan farm (Hebrew University, 
Israel); the Lgals1-/- (Gal1-KO) mutants of the B6 strain 
were kindly provided by Prof. Francoise Poirier (Institut 
Jacques Monod, Universités P6 and P7, Paris, France). The 
70% PHx or sham surgery was performed as described by 
Greene and Puder [44]. 
Isolation and analysis of total liver RNA and total 
liver protein
Total RNA was isolated from frozen liver tissues 
using Trizol reagent (Invitrogen, Carlsbad, CA) as 
described by the manufacturer. Gene expression was 
evaluated either by semi-qRT-PCR [15], or by real-time 
RT-PCR as described in the Supplementary Methods using 
primers described in Supplementary Table 1. Total liver 
protein was isolated and analyzed by immunoblotting as 
previously described [15].
Immunohistochemistry and counting of positive 
cells
Immunostaining was done on 4-μm-thick formalin-
fixed paraffin-embedded liver tissue sections by standard 
procedures. Antibodies used in this study and their 
antigen retrieval procedures are shown in Supplementary 
Table 2. Cas-Block™ (008120, Invitrogen, Carlsbad, 
CA, USA) was used for dilution of all antibodies as well 
as for tissue blocking. The following HRP-conjugated 
secondary antibodies were used: anti-rabbit (K4003), 
anti-mouse (K4001; both Envision, Dako, Denmark), 
anti-rat (Histofine, Nishirei, Japan). Color was developed 
using either 3-amino-9-ethylcarbazole (AEC, 00-1111, 
Invitrogen) for 10 min (30 min in the case of CD3) (Gal-
1, CD3, Ly6B, BrdU) or 3,3’-diaminobenzidene using a 
Zymed Super Picture kit (87-9663, Invitrogen, CA, USA) 
for 5 min ( β-catenin, cyclin D1, F4/80, p21). Counter 
stain was performed with filtered Cat-Haematoxylin 
(Pharmatrade, UAE). Negative controls were used by 
omitting the primary antibody, or using a Gal-1-KO liver 
in the case of Gal1. The stainings were visualized with 
the Nikon Eclipse E600 microscope equipped with the 
CellSens Entry imaging software (Olympus, Australia). 
Histological assessment of liver slides was performed by 
a clinical pathologist (O.P.) in a blind fashion. The number 
of F4/80+, cyclin D1, p21-expressing cells for each slide 
was calculated as the sum in the x20 or x40 microscope 
power field. Ten fields per slide were included, and a total 
of 4 or 5 mice per group were used. 
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Immunoblotting
Samples from the whole liver tissue lysates (50 
µg protein/lane) were resolved on SDS-PAGE (Hoefer 
Mighty small SE245, Pharmacia Biotech, USA ) and 
electrophoretically transferred (Trans-Blot Semi-dry, 
BioRad) onto PVDF membranes (Bio-Rad, CA, USA). 
Gal1 protein was detected with the above mentioned 
rabbit anti-Gal1 (1:5000). Mouse β-actin (1:200, Abcam, 
UK) was used as a control to monitor sample loading. The 
immunocomplexes were visualized using the anti-rabbit 
(1:300), or anti-mouse (1:200) antibodies described above 
for 45 min and the EZ-ECL detection system (Biological 
Industries, Beit Ha-Emek, Israel) or Amersham ECL 
Prime (RPN2232, GE Healthcare UK Ltd, England) for 
5 min.
Quantification of triglycerides in liver samples
Frozen liver tissues (~100 mg) were homogenized 
in 1 ml solution containing 5% NP-40 in water, slowly 
heated to 80-100°C in a water bath for 2-5 min until the 
NP-40 became cloudy, then were cooled down to room 
temperature. The heating was repeated one more time to 
sollubilize all triglycerides. The samples were centrifuged 
for 2 min to remove any insoluble material and diluted 
10-fold with dH
2
O before the assay, which was performed 
using the Triglyceride Quantification Colorimetric/
Fluorometric Kit (# K622, Biovision Inc., Milpitas, CA). 
In the assay, TGs were converted to free fatty acids and 
glycerol. The glycerol was then oxidized to generate 
a product which reacts with the probe to generate color 
(spectrophotometry at λ = 570 nm).
Statistical analysis
Statistical significance between groups was 
estimated using the two-tailed unpaired ttest. Results are 
expressed as the mean ±standard error of the mean (SEM); 
differences were considered significant at P < 0.05.
Abbreviations
Akt, phosphoinositide-dependent kinase 1 
(PDK1); ALT, alanine aminotransferase; ALP, alkaline 
phosphatase; Atf3, activating transcription factor 3; BrdU, 
bromodeoxyuridine; Gal-1, galectin-1; IL interleukin; 
H&E, hematoxylin and eosin; HPF, high power field; 
KO, knockout; Lgals1, galectin-1 gene symbol; LR, liver 
regeneration; Ltbr, lymphotoxin beta receptor; NF-κB, 
nuclear factor kappa B; PHx, partial hepatectomy; Plin, 
perilipin; RT-PCR, reverse transcription polymerase chain 
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